Aerovate Therapeutics, Inc. (AVTE)
9.80
0.00 (0.00%)
Inactive · Last trade price
on Apr 28, 2025
Aerovate Therapeutics Employees
Aerovate Therapeutics had 30 employees as of December 31, 2024. The number of employees decreased by 21 or -41.18% compared to the previous year.
Employees
30
Change (1Y)
-21
Growth (1Y)
-41.18%
Revenue / Employee
n/a
Profits / Employee
-$1,632,000
Market Cap
8.12M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 30 | -21 | -41.18% |
Dec 31, 2023 | 51 | 8 | 18.60% |
Dec 31, 2022 | 43 | 27 | 168.75% |
Dec 31, 2021 | 16 | - | - |
AVTE News
- 15 days ago - Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million - GlobeNewsWire
- 22 days ago - Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals - PRNewsWire
- 4 weeks ago - Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PRNewsWire
- 5 weeks ago - Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PRNewsWire
- 7 weeks ago - AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE - Business Wire
- 6 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - PRNewsWire
- 11 months ago - Aerovate Therapeutics to Explore Strategic Alternatives - GlobeNewsWire
- 11 months ago - Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announced byHolzer & Holzer, LLC - GlobeNewsWire